Regeneron Pharmaceuticals Inc (BSP:REGN34)
R$ 89.25 1.25 (1.42%) Market Cap: 590.31 Bil Enterprise Value: 549.72 Bil PE Ratio: 24.59 PB Ratio: 3.63 GF Score: 86/100

Regeneron Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript

Nov 15, 2023 / 02:30PM GMT
Release Date Price: R$64.26
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

Good afternoon, everyone. I was just joking with the Regeneron team that [if] there's a biotech bear market, I don't see it in London. These are packed rooms. It's really great to see everyone. And this is -- I also think that we're going to have an XBI rally. But that's my hot take for the day. That aside, I do have the pleasure of hosting the Regeneron team, Bob Landry, CFO; and then Ryan Crowe, Head of Investor Relations.

I will hand it off to them to make some introductory remarks and then we'll get started.

Ryan Crowe
Regeneron Pharmaceuticals, Inc. - VP of IR

Thanks, Akash. Great to be here again. And this is a very crowded conference. I think it might be time for a bigger hotel.

Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

The claustrophobia is a feature, not a [function].

Ryan Crowe
Regeneron Pharmaceuticals, Inc. - VP of IR

I see. Anyway, I'll do some FLS disclaimer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot